Late magnetic resonance imaging features of leukoencephalopathy in children with central nervous system tumours following high-dose methotrexate and neuraxis radiation therapy.

[1]  Amar Gajjar,et al.  Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors , 2003, Cancer.

[2]  L. D. Pozza,et al.  Activity of postoperative carboplatin, etoposide, and high-dose methotrexate in pediatric CNS embryonal tumors: results of a phase II study in newly diagnosed children. , 2002, Medical and pediatric oncology.

[3]  T. Merchant,et al.  Effect of therapeutic ionizing radiation on the human brain , 2001, Annals of neurology.

[4]  M. Forsting,et al.  White matter disease in children treated for malignant brain tumors , 2001, Child's Nervous System.

[5]  W E Reddick,et al.  Risks of young age for selected neurocognitive deficits in medulloblastoma are associated with white matter loss. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  W E Reddick,et al.  Subtle white matter volume differences in children treated for medulloblastoma with conventional or reduced dose craniospinal irradiation. , 2000, Magnetic resonance imaging.

[7]  R. Mulhern,et al.  Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  Z. Fuks,et al.  Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomyelinase deficiency. , 2000, Cancer research.

[9]  A. King,et al.  Late radiation injury to the temporal lobes: morphologic evaluation at MR imaging. , 1999, Radiology.

[10]  B. M. Lanning,et al.  A longitudinal magnetic resonance imaging study of the brain in survivors of childhood acute lymphoblastic leukemia , 1998, Cancer.

[11]  N. Winick,et al.  Acute neurotoxicity in children with B-precursor acute lymphoid leukemia: an association with intermediate-dose intravenous methotrexate and intrathecal triple therapy--a Pediatric Oncology Group study. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  J. Blay,et al.  High-dose methotrexate for the treatment of primary cerebral lymphomas: analysis of survival and late neurologic toxicity in a retrospective series. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  G. Schroth,et al.  Pure methotrexate encephalopathy presenting with seizures: CT and MRI features , 1998, Pediatric Radiology.

[14]  M. Skalej,et al.  CNS late effects after ALL therapy in childhood. Part I: Neuroradiological findings in long-term survivors of childhood ALL--an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group. , 1997, Medical and pediatric oncology.

[15]  N. Slevin,et al.  Late radiation change in the CNS: MR imaging following gadolinium enhancement. , 1997, Clinical radiology.

[16]  S. Higano,et al.  Leukoencephalopathy in childhood hematopoietic neoplasm caused by moderate-dose methotrexate and prophylactic cranial radiotherapy--an MR analysis. , 1995, International journal of radiation oncology, biology, physics.

[17]  W. Bleyer.  Leukoencephalopathy detectable by magnetic resonance imaging: much ado about nothing? Regarding Matsumoto et al. IJROBP 32:913-918; 1995. , 1995, International journal of radiation oncology, biology, physics.

[18]  T E Schultheiss,et al.  Radiation response of the central nervous system. , 1995, International journal of radiation oncology, biology, physics.

[19]  D. Nelson,et al.  White matter changes are correlated significantly with radiation dose. Observations from a randomized dose‐escalation trial for malignant glioma (radiation therapy oncology group 83‐02) , 1994, Cancer.

[20]  D. Nelson,et al.  Disruption of the blood-brain barrier as the primary effect of CNS irradiation. , 1994, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[21]  E. Pääkkö,et al.  White matter changes in children treated for acute lymphoblastic leukemia , 1992, Cancer.

[22]  M. Ishikawa,et al.  A case of treatment-related leukoencephalpathy: sequential MRI, CT and PET findings , 1992, Journal of Neuro-Oncology.

[23]  W. Ball,et al.  Neurotoxicity of radio/chemotherapy in children: pathologic and MR correlation. , 1992, AJNR. American journal of neuroradiology.

[24]  M. Ito,et al.  Early diagnosis of leukoencephalopathy of acute lymphocytic leukemia by MRI. , 1991, Pediatric neurology.

[25]  J. R. Prince,et al.  Transient white matter changes on MR images in children undergoing chemotherapy for acute lymphocytic leukemia: correlation with neuropsychologic deficiencies. , 1991, Radiology.

[26]  G. Rosen,et al.  Preradiation high-dose intravenous methotrexate with leucovorin rescue for untreated primary childhood brain tumors. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27]  S Ekholm,et al.  Adverse effects of brain irradiation correlated with MR and CT imaging. , 1987, International journal of radiation oncology, biology, physics.

[28]  R A Zimmerman,et al.  Magnetic resonance imaging of cranial radiation lesions. , 1987, International journal of radiation oncology, biology, physics.

[29]  R. Zimmerman,et al.  Magnetic resonance imaging in the evaluation of treatment‐related central nervous system damage , 1986, Cancer.

[30]  W. Kinkel,et al.  Computed tomography brain scans in children with acute lymphocytic leukemia receiving methotrexate alone as central nervous system prophylaxis , 1980, Cancer.

[31]  P. Burger,et al.  The morphologic effects of radiation administered therapeutically for intracranial gliomas.A Postmortem study of 25 cases , 1979, Cancer.

[32]  G. Chiro,et al.  Abnormal CT Scans of the Brain in Asymptomatic Children with Acute Lymphocytic Leukemia after Prophylactic Treatment of the Central Nervous System with Radiation and Intrathecal Chemotherapy , 1978 .

[33]  A. Evans,et al.  Effects of chemotherapy on the central nervous system—A study of parenteral methotrexate in long‐term survivors of leukemia and lymphoma in childhood , 1976, Cancer.

[34]  D. Rottenberg,et al.  Leukoencephalopathy following high-dose intravenous methotrexate chemotherapy: Quantitative assessment of white matter attenuation using computed tomography , 2004, Neuroradiology.

[35]  M. Mayberg,et al.  Effects of radiation on cerebral vasculature: a review. , 2000, Neurosurgery.

[36]  W. Bleyer.  Chemoradiotherapy interactions in the central nervous system. , 1998, Medical and pediatric oncology.

[37]  D. Caramella,et al.  Brain damage after treatment for acute lymphoblastic leukemia. A report on 34 patients with special regard to MRI findings. , 1989, Acta oncologica.

[38]  L. Rorke,et al.  Long-term sequelae of cancer treatment on the central nervous system in childhood. , 1987, Medical and pediatric oncology.

[39]  R. Aur,et al.  Progression of methotrexate-induced leukoencephalopathy in children with leukemia. , 1981, Medical and pediatric oncology.

[40]  W. Bleyer.  Neurologic sequelae of methotrexate and ionizing radiation: a new classification. , 1981, Cancer treatment reports.

[41]  G. Rosen,et al.  Leukoencephalopathy following high-dose iv methotrexate chemotherapy with leucovorin rescue. , 1980, Cancer treatment reports.